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Nuovo Ospedale San Giovanni di L>io of Florence, thus 
covering all the hospitals in the ]'lorentine area. 
One hundred and eighty-nine isolates of entero- 
cocci from blood cultures performed during 1990-95, 
one strain per patient, were studied. There were 126 
strains of E.faecalis, 46 E. faeciuiir, 12 E. avium, two E. 
durans, two E. gallinarum, and one E. mundtii. Entero- 
coccal strains were identified and tested for their 
antimicrobial susceptibility with the automated Vitek 
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Recently enterococci have emerged as increasingly 
prominent pathogens in nosocomial infections [I]. The 
standard treatment for serious enterococcal infections is 
a bactericidal and synergistic combination of a p-lactam 
antibiotic (ampicillin or benzylpenicillin) or vanco- 
inycin with an aiiiinoglycoside [2]. Unfortunately, 
during the 1980s, high-level resistance (MIC> 2000 
nig/L) of enterococci to aniinoglycosides caused by 
aminoglycoside-modifying enzymes emerged rapidly, 
making the treatment of such infections difficult [3]. 
Since the late 1980s, glycopeptide-resistant enterococci 
have been reported in many parts of the world [4]. 
Most reports have described clusters of nosocomial 
infections 151. N o  established therapy exists for life- 
threatening diseases caused by such organisms. 
We previously reported the prevalence of high- 
level resistance to aiiiinoglycosides among enterococci 
isolated from blood cultures submitted to the Labora- 
torio di Microbiologia e Virologia of the Policlinico 
Careggi, Florence, Italy, from March 1990 to June 1991 
[6]. In that study, we found that 65.2% of Entevococcus 
.fac.calis strains were highly resistant to gentamicin, 
47.8% were highly streptoinicin resistant, and 86.9% 
were resistant to at least one of the aminoglycosides 
tested. We have continued monitoring this pheno- 
menon in Florence and we now report data on entero- 
coccal strains isolated from blood cultures updated to 
the end of 1995. From January 1995 we included the 
system (bioMkrieux, Marcy l'Etoile, France), which 
includes a screening test for highlevel aminoglycoside 
resistance, supplemented with 1:ests for motility and 
pigment production. The results are summarized in 
Table 1 .  The susceptibility card (GPS-TA) utilized from 
1990 to 1994 allowed detection of high-level resistance 
to gentanllcin (500 mg/L) and streptomycin (2000 
mg/L). Since January 1995, a different card (GPS-IR) 
has been used to determine the mtimicrobial suscepti- 
bility of enterococci. This card irtcludes a screening test 
for high-level gentamkin resistaiice only. A inicrotiter 
broth dilution method was utilized to detect strepto- 
mycin resistance and to confirm the resistance data 
obtained by the Vitek system. Broth microdilution 
minimum inhibitory concentrations (MICs) of vanco- 
mycin and teicoplanin were determined for strains that 
were shown to be glycopeptide resistant by the Vitek 
system. P-Lactamase production was tested with the 
chromogenic cephalosporin nitrocefin. 
In the last three years there has been a significant 
decrease in the prevalence of E. ,.faeralis highly resistant 
to gentamicin, in comparison with the three preceding 
years (chi"4.56; p<0.05). We did not find any 
particular explanation for this finding, and the low 
number of strains calls for caucion in formulating a 
hypothesis. Smaller variations were observed in strepto- 
mycin resistance. Twenty-three of 27 (85.2%) E. j&ralis 
strains with high-level resistance to gentanllciii isolated 
in the last three years were also highly resistant to 
streptomycin. No P-lactamase--producing strains of 
enterococci were found during the study period. 
In August 1994, a vancomytzin-resistant E. faeciuin 
strain (yielded in two blood cultures) was first isolated 
in Florence from a 46-year-old man with acute rnyeloid 
leukemia in the hematology unit of Careggi Hospital. 
In January 1995, a second vaiiconiycin-resistant E.  
faeciurn strain (yielded in three blood cultures) was 
recovered from a 74-year-old woman who had under- 
gone an operation for an aneurysm of the left carotid 
in the neurosurgery unit of the same hospital. Both 
isolates showed the Van A phenotype: MICs of vanco- 
mycin and teicoplaniii were 256 and 32 mg/L, and 256 
and 64 nig/L, respectively, for the two strains. Pulsed- 
field gel electrophoresis (PFGE)--based restriction frag- 
ment length polymorphism (1)NA RFLP) analysis 
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revealed different profiles after SniaI digestion [7],  
showing that they were epidemiologically unrelated 
(data not shown). The durations of the hospital stays 
before isolation of vancomycin-resistant enterococci 
were 26 and 31 days, respectively, for the two patients; 
both had been treated earlier with glycopeptide anti- 
biotics (vancomycin associated with gentamicin for 
8 days, and teicoplanin for 7 days, respectively). 
The results of the continuing surveillance show 
that high-level aminoglycoside resistance continues to 
be a real problem in our hospitals. The presence of 
high-level resistance to both gentanllcin and strepto- 
mycin in 85.2% of E. faecalis strains isolated from blood 
cultures in the last two years is a matter of particular 
concern. The screening of enterococci for high-level 
aminoglycoside resistance remains essential before 
treating patients with serious enterococcal infections, 
such as endocarditis or meningitis. 
Our study is ongoing and will permit us to monitor 
the occurrence of vancomycin-resistant enterococci in 
the hospitals in the Florence area. Current evidence 
highlights the importance of effective infection control 
measures for preventing the spread of vanconiycin- 
resistant enterococci [ 8 ] .  In addition, medical staff 
should be made aware of the gravity of the problem, 
and a more judicious use of glycopeptide antibiotics, as 
well as broad-spectrum antimicrobials such as cephalo- 
sporins, is strongly recommended. 
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Long-standing bacteremia and endocarditis caused by 
Sraphylococcus lugdunensis in a patient with an 
implantable cardioverter defibrillator 
Clin Microbiol Ir@ct 1997; 3: 387-388 
Implantable cardioverter defibrillators (ICDs) are being 
used for the treatment of life-threatening ventricular 
arrythniias. Colonization of all parts of the device, 
including the rate-sensing electrodes, patches or pulse 
generator, has been described in -2-6”c [ I  1. Most such 
infections are due to staphylococci. Infections are most 
reliably treated by complete removal of the device and 
antibiotic administration. In rare cases, patients may 
respond to a combination of intravenous antibiotics 
and removal and replacement of only the generator, 
leaving the electrodes [l]. Stupliylooccus lugdunensis is a 
coagulase-negative Staphylococcus sp. which causes soft 
tissue abscesses and endocarditis involving native and 
prosthetic valves [2,3]. We report here a case of long- 
standing bacteremia due to s. lugdunensis in a patient 
with an implantable cardioverter defibrillator, who was 
treated with multiple courses of antibiotics and was 
cured only when the device was surgically replaced 
5 years later. We provide evidence of the identity of 
isolates of S. lngduiiensis recovered from the removed 
device and the blood cultures collected over a 5-year 
period, by determining their pulsed-field gel electro- 
phoresis profiles. 
Case report 
A 41-year-old inan was adniitttd in February 1996 
to Louis Pradel Hospital (Lyon., France) because of 
recurrent fevers. Five years behre  admission (April 
1991) a cardioverter defibrillator had been implanted. 
The febrile attacks begun 2 days after defibrillator 
implantation and a purulent collection surrounding 
the pulse generator was observed. No bacteria were 
isolated from the pus or blood Icultures. The paticnt 
was treated with cefazolin and netilniicin followed by 
pristinaniycin for 1 month. Three months later (July 
1991), he developed a new febrile episode, and cix 
blood cultures (Vital System, IiioMt-rieux, Marcy- 
I’Etoile, France) yielded S. Iugdurierisis susceptible to all 
antistaphylococcal antibiotics, including benzylpeni- 
cillin. Local skin inflammation was observed around 
the device. The patient received intravenous oxacilliri 
and aniikacin for 1 month, followed by oral oxacillin 
for 1 month. Seven months later (February 1992), a 
surgically drained collection of fluid around the device 
grew S. lugdtrnensis. Antistaphy1o’;occal antibiotherapy 
(intravenous teicoplanin and oral fusidic acid) was given 
again for 5 weeks. followed by oral pristinamycin 
for 4 months. The patient was considered cured until 
February 2996, when a new febrile episode occurred 
and four blood cultures again yielded S. Iiqduncnsis. An 
infected cardioverter defibrillato-r was suspected, and 
all of the material was surgically removed without 
reinsertion. Culture of the rate-sensing electrode yielded 
S. lugdurzensis. A pulmonary embolus occurred 4 days 
after surgery and a vegetation consistent with infective 
endocarditis was visualized by echocardiography on the 
posterior leaflet of the tricuspid valve. Although blood 
cultures obtained after explantation of the device did 
not yield any growth of S. liqdunenris, the patient 
received 6 weeks of antistaphylococcal antibiotic therapy 
as treatment for endocarditis. He  has not had any febrile 
episodes since, and his physical condition has improved 
rapidly. I n  order to study the possible identity of the 
S. lu‘qdtrrzerisir isolates, chromosomal DNA fragments 
generated by cleavage with restriction endonuclease 
SnzuI were separated by pulsed-fie Id gel electrophoresis, 
according to the method described by Lina et a1 141. 
We found no differences among the digestion patterns 
of any of the isolates (Figure 1). Moreover, most of 
the 1 1 independently isolated strains from patients 
with S. luqdunensis infective mdocarditis, corres- 
ponding to a series previously reported [Z], have 
different digestion patterns and none had patterns 
identical to those from this patient (Figure 1).  We 
conclude that all the S. lugduncrisis isolates from our 
patient were from one clone and that the infection was 
due to the same infecting organism, which persisted 
for 5 years. S. lugdunensis has been regarded as a species, 
